XML 37 R11.htm IDEA: XBRL DOCUMENT v3.20.1
Fair Value of Financial Instruments
3 Months Ended
Mar. 31, 2020
Fair Value of Financial Instruments  
Fair Value of Financial Instruments

4. Fair Value of Financial Instruments

Fair value is the price that could be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. Fair value determination in accordance with applicable accounting guidance requires that a number of significant judgments be made. Additionally, fair value is used on a nonrecurring basis to evaluate assets for impairment or as required for disclosure purposes by applicable accounting guidance on disclosures about fair value of financial instruments. Depending on the nature of the assets and liabilities, various valuation techniques and assumptions are used when estimating fair value. The carrying amounts of certain of the Company’s financial instruments, including prepaid expense and accounts payable are shown at cost, which approximates fair value due to the short‑term nature of these instruments. The Company follows the provisions of FASB ASC Topic 820, Fair Value Measurement, for financial assets and liabilities measured on a recurring basis. The guidance requires fair value measurements be classified and disclosed in one of the following three categories:

·

Level 1:  Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

·

Level 2:  Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liabilities.

·

Level 3:  Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

The following fair value hierarchy table presents information about the Company’s assets measured at fair value on a recurring basis:

 

 

 

 

 

 

 

 

 

 

 

 

Fair value measurement at

 

 

reporting date using

 

 

Quoted prices

 

 

 

 

 

 

 

 

in active

 

Significant

 

 

 

 

 

 

markets for

 

other

 

Significant

 

 

identical

 

observable

 

 

unobservable

 

 

assets

 

inputs

 

inputs

(in thousands)

    

(Level 1)

    

(Level 2)

    

(Level 3)

March 31, 2020:

 

 

  

 

 

  

 

 

  

Assets:

 

 

  

 

 

  

 

 

  

Cash equivalents (Money Market Fund)

 

$

284,173

 

$

 —

 

$

 —

December 31, 2019:

 

 

  

 

 

  

 

 

  

Assets:

 

 

  

 

 

  

 

 

  

Cash equivalents (Money Market Fund)

 

$

155,846

 

$

 —

 

$

 —

 

 

 

The Company evaluated the future tranche right feature within the Series A-1 convertible preferred stock issued in 2018 and determined that the future tranche right was a freestanding financial instrument that was classified as a liability and was re-measured at each reporting period until the redemption feature was exercised in connection with the sale and issuance of the Series A-2 convertible preferred stock in May 2019.